BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Vancouver
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211007T093000
DTEND;TZID=America/Vancouver:20211007T110000
DTSTAMP:20260404T045652
CREATED:20211004T165740Z
LAST-MODIFIED:20211004T165740Z
UID:18631-1633599000-1633604400@scienceinvancouver.com
SUMMARY:Blakes Breakfast Speaking Series
DESCRIPTION:A new class of drugs is emerging to expand the spectrum of treatments for cancer\, called radiopharmaceuticals\, which deliver radiation directly and specifically to cancer cells.  These drugs contain radioactive isotopes and can be used as both diagnostic and therapeutic agents. \nTargeting radiation therapy at the cellular level has the potential to reduce the risk of both short-term and long-term side effects of treatment\, while proving effective at killing even the small clusters of cancer cells throughout the body. \nReduced side effects and precision delivery are driving the interest and high growth in this new generation of radiopharmaceuticals. A number of new therapies are emerging\, including using lutetium-177 to treat prostate and neuroendocrine cancers. The global market for radiopharmaceuticals was estimated at $6.1 billion in 2019\, and is projected to reach $12.6 billion by 2027. \nThe Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. These breakfasts include presentations by local\, national\, and multinational life science companies and typically attract a cross-section of approximately 75 of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \nSpeakers:\n\nNoël Brown\, Managing Director & Head of U.S. Biotechnology Investment Banking\, RBC Capital Markets\nKathryn Hayashi\, President & CEO\, TRIUMF Innovations\nDr. Lana Janes\, Venture Partner at adMare BioInnovations\, Interim CEO at Abdera Therapeutics\nCody Shirriff\, CEO & Founder\, Serenity Bioworks\n\nEvent Details:\nDate: October 7\, 2021 \nTime: 9:30 AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/blakes-breakfast-speaking-series/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Blakes-Breakfast-Main-Image-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211007T093000
DTEND;TZID=America/Vancouver:20211007T110000
DTSTAMP:20260404T045652
CREATED:20211004T165740Z
LAST-MODIFIED:20211004T165740Z
UID:26443-1633599000-1633604400@scienceinvancouver.com
SUMMARY:Blakes Breakfast Speaking Series
DESCRIPTION:A new class of drugs is emerging to expand the spectrum of treatments for cancer\, called radiopharmaceuticals\, which deliver radiation directly and specifically to cancer cells.  These drugs contain radioactive isotopes and can be used as both diagnostic and therapeutic agents. \nTargeting radiation therapy at the cellular level has the potential to reduce the risk of both short-term and long-term side effects of treatment\, while proving effective at killing even the small clusters of cancer cells throughout the body. \nReduced side effects and precision delivery are driving the interest and high growth in this new generation of radiopharmaceuticals. A number of new therapies are emerging\, including using lutetium-177 to treat prostate and neuroendocrine cancers. The global market for radiopharmaceuticals was estimated at $6.1 billion in 2019\, and is projected to reach $12.6 billion by 2027. \nThe Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. These breakfasts include presentations by local\, national\, and multinational life science companies and typically attract a cross-section of approximately 75 of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \nSpeakers:\n\nNoël Brown\, Managing Director & Head of U.S. Biotechnology Investment Banking\, RBC Capital Markets\nKathryn Hayashi\, President & CEO\, TRIUMF Innovations\nDr. Lana Janes\, Venture Partner at adMare BioInnovations\, Interim CEO at Abdera Therapeutics\nCody Shirriff\, CEO & Founder\, Serenity Bioworks\n\nEvent Details:\nDate: October 7\, 2021 \nTime: 9:30 AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/blakes-breakfast-speaking-series-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Blakes-Breakfast-Main-Image-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211007T093000
DTEND;TZID=America/Vancouver:20211007T110000
DTSTAMP:20260404T045652
CREATED:20211004T165740Z
LAST-MODIFIED:20211004T165740Z
UID:28058-1633599000-1633604400@scienceinvancouver.com
SUMMARY:Blakes Breakfast Speaking Series
DESCRIPTION:A new class of drugs is emerging to expand the spectrum of treatments for cancer\, called radiopharmaceuticals\, which deliver radiation directly and specifically to cancer cells.  These drugs contain radioactive isotopes and can be used as both diagnostic and therapeutic agents. \nTargeting radiation therapy at the cellular level has the potential to reduce the risk of both short-term and long-term side effects of treatment\, while proving effective at killing even the small clusters of cancer cells throughout the body. \nReduced side effects and precision delivery are driving the interest and high growth in this new generation of radiopharmaceuticals. A number of new therapies are emerging\, including using lutetium-177 to treat prostate and neuroendocrine cancers. The global market for radiopharmaceuticals was estimated at $6.1 billion in 2019\, and is projected to reach $12.6 billion by 2027. \nThe Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. These breakfasts include presentations by local\, national\, and multinational life science companies and typically attract a cross-section of approximately 75 of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \nSpeakers:\n\nNoël Brown\, Managing Director & Head of U.S. Biotechnology Investment Banking\, RBC Capital Markets\nKathryn Hayashi\, President & CEO\, TRIUMF Innovations\nDr. Lana Janes\, Venture Partner at adMare BioInnovations\, Interim CEO at Abdera Therapeutics\nCody Shirriff\, CEO & Founder\, Serenity Bioworks\n\nEvent Details:\nDate: October 7\, 2021 \nTime: 9:30 AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/blakes-breakfast-speaking-series-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Blakes-Breakfast-Main-Image-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211007T093000
DTEND;TZID=America/Vancouver:20211007T110000
DTSTAMP:20260404T045652
CREATED:20211004T165740Z
LAST-MODIFIED:20211004T165740Z
UID:31141-1633599000-1633604400@scienceinvancouver.com
SUMMARY:Blakes Breakfast Speaking Series
DESCRIPTION:A new class of drugs is emerging to expand the spectrum of treatments for cancer\, called radiopharmaceuticals\, which deliver radiation directly and specifically to cancer cells.  These drugs contain radioactive isotopes and can be used as both diagnostic and therapeutic agents. \nTargeting radiation therapy at the cellular level has the potential to reduce the risk of both short-term and long-term side effects of treatment\, while proving effective at killing even the small clusters of cancer cells throughout the body. \nReduced side effects and precision delivery are driving the interest and high growth in this new generation of radiopharmaceuticals. A number of new therapies are emerging\, including using lutetium-177 to treat prostate and neuroendocrine cancers. The global market for radiopharmaceuticals was estimated at $6.1 billion in 2019\, and is projected to reach $12.6 billion by 2027. \nThe Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. These breakfasts include presentations by local\, national\, and multinational life science companies and typically attract a cross-section of approximately 75 of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \nSpeakers:\n\nNoël Brown\, Managing Director & Head of U.S. Biotechnology Investment Banking\, RBC Capital Markets\nKathryn Hayashi\, President & CEO\, TRIUMF Innovations\nDr. Lana Janes\, Venture Partner at adMare BioInnovations\, Interim CEO at Abdera Therapeutics\nCody Shirriff\, CEO & Founder\, Serenity Bioworks\n\nEvent Details:\nDate: October 7\, 2021 \nTime: 9:30 AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/blakes-breakfast-speaking-series-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Blakes-Breakfast-Main-Image-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211007T093000
DTEND;TZID=America/Vancouver:20211007T110000
DTSTAMP:20260404T045652
CREATED:20211004T165740Z
LAST-MODIFIED:20211004T165740Z
UID:32601-1633599000-1633604400@scienceinvancouver.com
SUMMARY:Blakes Breakfast Speaking Series
DESCRIPTION:A new class of drugs is emerging to expand the spectrum of treatments for cancer\, called radiopharmaceuticals\, which deliver radiation directly and specifically to cancer cells.  These drugs contain radioactive isotopes and can be used as both diagnostic and therapeutic agents. \nTargeting radiation therapy at the cellular level has the potential to reduce the risk of both short-term and long-term side effects of treatment\, while proving effective at killing even the small clusters of cancer cells throughout the body. \nReduced side effects and precision delivery are driving the interest and high growth in this new generation of radiopharmaceuticals. A number of new therapies are emerging\, including using lutetium-177 to treat prostate and neuroendocrine cancers. The global market for radiopharmaceuticals was estimated at $6.1 billion in 2019\, and is projected to reach $12.6 billion by 2027. \nThe Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. These breakfasts include presentations by local\, national\, and multinational life science companies and typically attract a cross-section of approximately 75 of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \nSpeakers:\n\nNoël Brown\, Managing Director & Head of U.S. Biotechnology Investment Banking\, RBC Capital Markets\nKathryn Hayashi\, President & CEO\, TRIUMF Innovations\nDr. Lana Janes\, Venture Partner at adMare BioInnovations\, Interim CEO at Abdera Therapeutics\nCody Shirriff\, CEO & Founder\, Serenity Bioworks\n\nEvent Details:\nDate: October 7\, 2021 \nTime: 9:30 AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/blakes-breakfast-speaking-series-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Blakes-Breakfast-Main-Image-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211007T120000
DTEND;TZID=America/Vancouver:20211007T230000
DTSTAMP:20260404T045652
CREATED:20210920T025525Z
LAST-MODIFIED:20210920T025525Z
UID:18377-1633608000-1633647600@scienceinvancouver.com
SUMMARY:CHÉOS Lunch and Learn: Modernizing Clinical Trial Regulations
DESCRIPTION:Presented by CHÉOS Director of Regulatory Affairs & Quality Assurance\, Dana Nohynek\, this presentation will cover Health Canada’s current thinking on opportunities to enhance regulatory agility and support innovation through a flexible and risk-based framework.
URL:https://scienceinvancouver.com/event/cheos-lunch-and-learn-modernizing-clinical-trial-regulations/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211007T120000
DTEND;TZID=America/Vancouver:20211007T230000
DTSTAMP:20260404T045652
CREATED:20210920T025525Z
LAST-MODIFIED:20210920T025525Z
UID:26437-1633608000-1633647600@scienceinvancouver.com
SUMMARY:CHÉOS Lunch and Learn: Modernizing Clinical Trial Regulations
DESCRIPTION:Presented by CHÉOS Director of Regulatory Affairs & Quality Assurance\, Dana Nohynek\, this presentation will cover Health Canada’s current thinking on opportunities to enhance regulatory agility and support innovation through a flexible and risk-based framework.
URL:https://scienceinvancouver.com/event/cheos-lunch-and-learn-modernizing-clinical-trial-regulations-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211007T120000
DTEND;TZID=America/Vancouver:20211007T230000
DTSTAMP:20260404T045652
CREATED:20210920T025525Z
LAST-MODIFIED:20210920T025525Z
UID:28052-1633608000-1633647600@scienceinvancouver.com
SUMMARY:CHÉOS Lunch and Learn: Modernizing Clinical Trial Regulations
DESCRIPTION:Presented by CHÉOS Director of Regulatory Affairs & Quality Assurance\, Dana Nohynek\, this presentation will cover Health Canada’s current thinking on opportunities to enhance regulatory agility and support innovation through a flexible and risk-based framework.
URL:https://scienceinvancouver.com/event/cheos-lunch-and-learn-modernizing-clinical-trial-regulations-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211007T120000
DTEND;TZID=America/Vancouver:20211007T230000
DTSTAMP:20260404T045652
CREATED:20210920T025525Z
LAST-MODIFIED:20210920T025525Z
UID:31135-1633608000-1633647600@scienceinvancouver.com
SUMMARY:CHÉOS Lunch and Learn: Modernizing Clinical Trial Regulations
DESCRIPTION:Presented by CHÉOS Director of Regulatory Affairs & Quality Assurance\, Dana Nohynek\, this presentation will cover Health Canada’s current thinking on opportunities to enhance regulatory agility and support innovation through a flexible and risk-based framework.
URL:https://scienceinvancouver.com/event/cheos-lunch-and-learn-modernizing-clinical-trial-regulations-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211007T120000
DTEND;TZID=America/Vancouver:20211007T230000
DTSTAMP:20260404T045652
CREATED:20210920T025525Z
LAST-MODIFIED:20210920T025525Z
UID:32595-1633608000-1633647600@scienceinvancouver.com
SUMMARY:CHÉOS Lunch and Learn: Modernizing Clinical Trial Regulations
DESCRIPTION:Presented by CHÉOS Director of Regulatory Affairs & Quality Assurance\, Dana Nohynek\, this presentation will cover Health Canada’s current thinking on opportunities to enhance regulatory agility and support innovation through a flexible and risk-based framework.
URL:https://scienceinvancouver.com/event/cheos-lunch-and-learn-modernizing-clinical-trial-regulations-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211019T123000
DTEND;TZID=America/Vancouver:20211019T133000
DTSTAMP:20260404T045652
CREATED:20211014T200153Z
LAST-MODIFIED:20211018T202947Z
UID:18785-1634646600-1634650200@scienceinvancouver.com
SUMMARY:Seminar - Patrolling Monocyte Development and Regulation of Obesity\, Tumour Metastasis\, and Alzheimer’s Disease
DESCRIPTION:The University of British Columbia Department of Microbiology and Immunology presents a seminar by:\n\n\n\n\nJessica Silva\n\n\nPhD Candidate\n  \n\nentitled:\n\nSeminar – Patrolling Monocyte Development And Regulation Of Obesity\, Tumour Metastasis and Alzheimer’s Disease\n  \n\n\n\n\n \nSponsored by: The Department of Microbiology and Immunology \nPlease note that our seminars will be Hybrid (in-person & Zoom). The seminar will be in LSC3 but if you prefer to join via Zoom please contact parvin@mail.ubc.ca(link sends e-mail) for how to join!\n\n\n\nTuesday\, October 19\, 2021 – 12:30pm to 1:30pm\nLocation: \nLife Sciences Centre\, LSC 3\n2350 Health Sciences Mall\n\n\nHosted by \nDr. Ken Harder
URL:https://scienceinvancouver.com/event/seminar-patrolling-monocyte-development-and-regulation-of-obesity-tumour-metastasis-and-alzheimers-disease/
LOCATION:Life Sciences Centre\, 2350 Health Sciences Mall\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211019T123000
DTEND;TZID=America/Vancouver:20211019T133000
DTSTAMP:20260404T045652
CREATED:20211014T200153Z
LAST-MODIFIED:20211014T200153Z
UID:26447-1634646600-1634650200@scienceinvancouver.com
SUMMARY:Seminar - Patrolling Monocyte Development and Regulation of Obesity\, Tumour Metastasis\, and Alzheimer’s Disease
DESCRIPTION:The University of British Columbia Department of Microbiology and Immunology presents a seminar by:\n\n\n\n\nJessica Silva\n\n\nPhD Candidate\n  \n\nentitled:\n\nSeminar – Patrolling Monocyte Development And Regulation Of Obesity\, Tumour Metastasis and Alzheimer’s Disease\n  \n\n\n\n\n \nSponsored by: The Department of Microbiology and Immunology \nPlease note that our seminars will be Hybrid (in-person & Zoom). The seminar will be in LSC3 but if you prefer to join via Zoom please contact parvin@mail.ubc.ca(link sends e-mail) for how to join!\n\n\n\nTuesday\, October 19\, 2021 – 12:30pm to 1:30pm\nLocation: \nLife Sciences Centre\, LSC 3\n2350 Health Sciences Mall\n\n\nHosted by \nDr. Ken Harder
URL:https://scienceinvancouver.com/event/seminar-patrolling-monocyte-development-and-regulation-of-obesity-tumour-metastasis-and-alzheimers-disease-2/
LOCATION:Life Sciences Centre\, 2350 Health Sciences Mall\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211019T123000
DTEND;TZID=America/Vancouver:20211019T133000
DTSTAMP:20260404T045652
CREATED:20211014T200153Z
LAST-MODIFIED:20211014T200153Z
UID:28062-1634646600-1634650200@scienceinvancouver.com
SUMMARY:Seminar - Patrolling Monocyte Development and Regulation of Obesity\, Tumour Metastasis\, and Alzheimer’s Disease
DESCRIPTION:The University of British Columbia Department of Microbiology and Immunology presents a seminar by:\n\n\n\n\nJessica Silva\n\n\nPhD Candidate\n  \n\nentitled:\n\nSeminar – Patrolling Monocyte Development And Regulation Of Obesity\, Tumour Metastasis and Alzheimer’s Disease\n  \n\n\n\n\n \nSponsored by: The Department of Microbiology and Immunology \nPlease note that our seminars will be Hybrid (in-person & Zoom). The seminar will be in LSC3 but if you prefer to join via Zoom please contact parvin@mail.ubc.ca(link sends e-mail) for how to join!\n\n\n\nTuesday\, October 19\, 2021 – 12:30pm to 1:30pm\nLocation: \nLife Sciences Centre\, LSC 3\n2350 Health Sciences Mall\n\n\nHosted by \nDr. Ken Harder
URL:https://scienceinvancouver.com/event/seminar-patrolling-monocyte-development-and-regulation-of-obesity-tumour-metastasis-and-alzheimers-disease-3/
LOCATION:Life Sciences Centre\, 2350 Health Sciences Mall\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211019T123000
DTEND;TZID=America/Vancouver:20211019T133000
DTSTAMP:20260404T045652
CREATED:20211014T200153Z
LAST-MODIFIED:20211014T200153Z
UID:31145-1634646600-1634650200@scienceinvancouver.com
SUMMARY:Seminar - Patrolling Monocyte Development and Regulation of Obesity\, Tumour Metastasis\, and Alzheimer’s Disease
DESCRIPTION:The University of British Columbia Department of Microbiology and Immunology presents a seminar by:\n\n\n\n\nJessica Silva\n\n\nPhD Candidate\n  \n\nentitled:\n\nSeminar – Patrolling Monocyte Development And Regulation Of Obesity\, Tumour Metastasis and Alzheimer’s Disease\n  \n\n\n\n\n \nSponsored by: The Department of Microbiology and Immunology \nPlease note that our seminars will be Hybrid (in-person & Zoom). The seminar will be in LSC3 but if you prefer to join via Zoom please contact parvin@mail.ubc.ca(link sends e-mail) for how to join!\n\n\n\nTuesday\, October 19\, 2021 – 12:30pm to 1:30pm\nLocation: \nLife Sciences Centre\, LSC 3\n2350 Health Sciences Mall\n\n\nHosted by \nDr. Ken Harder
URL:https://scienceinvancouver.com/event/seminar-patrolling-monocyte-development-and-regulation-of-obesity-tumour-metastasis-and-alzheimers-disease-4/
LOCATION:Life Sciences Centre\, 2350 Health Sciences Mall\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211019T123000
DTEND;TZID=America/Vancouver:20211019T133000
DTSTAMP:20260404T045652
CREATED:20211014T200153Z
LAST-MODIFIED:20211014T200153Z
UID:32605-1634646600-1634650200@scienceinvancouver.com
SUMMARY:Seminar - Patrolling Monocyte Development and Regulation of Obesity\, Tumour Metastasis\, and Alzheimer’s Disease
DESCRIPTION:The University of British Columbia Department of Microbiology and Immunology presents a seminar by:\n\n\n\n\nJessica Silva\n\n\nPhD Candidate\n  \n\nentitled:\n\nSeminar – Patrolling Monocyte Development And Regulation Of Obesity\, Tumour Metastasis and Alzheimer’s Disease\n  \n\n\n\n\n \nSponsored by: The Department of Microbiology and Immunology \nPlease note that our seminars will be Hybrid (in-person & Zoom). The seminar will be in LSC3 but if you prefer to join via Zoom please contact parvin@mail.ubc.ca(link sends e-mail) for how to join!\n\n\n\nTuesday\, October 19\, 2021 – 12:30pm to 1:30pm\nLocation: \nLife Sciences Centre\, LSC 3\n2350 Health Sciences Mall\n\n\nHosted by \nDr. Ken Harder
URL:https://scienceinvancouver.com/event/seminar-patrolling-monocyte-development-and-regulation-of-obesity-tumour-metastasis-and-alzheimers-disease-5/
LOCATION:Life Sciences Centre\, 2350 Health Sciences Mall\, Vancouver
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211020T100000
DTEND;TZID=America/Vancouver:20211020T110000
DTSTAMP:20260404T045652
CREATED:20211004T165959Z
LAST-MODIFIED:20211004T165959Z
UID:18635-1634724000-1634727600@scienceinvancouver.com
SUMMARY:From Discovery to Market: The Role of IP Strategy in Drug Development
DESCRIPTION:Drug development in Canada is a long and complex process\, and the market is competitive. At the heart of drug development is intellectual property (IP). Life sciences companies who develop an IP strategy at the outset of a new project have a competitive advantage by creating value\, generating revenue\, and obtaining market intelligence. Without a strategy\, companies risk losing IP assets\, missing out on investment opportunities\, and being exposed to competition. \nOn Wednesday\, October 20\, join a panel of industry insiders who will discuss the key IP opportunities and strategies related to drug development in Canada. The panel will touch on everything from identifying intellectual property during R&D to the importance of freedom to operate analysis\, international filing strategies and portfolio management\, and of course\, the unique industry challenges brought to light due to the COVID-19 pandemic. \n\n\n\n\n\n\nSpeakers:  \n\nBrian Kingwell\, Partner\, Gowling WLG\nIsabelle Riedl\, Senior Supervisor\, Intellectual Property\, Medicago\nSonia Ziesche\, Principal\, Patent Agent\, Gowling WLG\n\n\n\n\n\n\n\n\n\n\n\n\nEvent Details:\n\n\n\n\n\n\n\n\n\n\n\nDate: Wednesday\, October 20\, 2021 \nTime: 10:00AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/from-discovery-to-market-the-role-of-ip-strategy-in-drug-development/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Gowling-Event-Images-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211020T100000
DTEND;TZID=America/Vancouver:20211020T110000
DTSTAMP:20260404T045652
CREATED:20211004T165959Z
LAST-MODIFIED:20211004T165959Z
UID:26444-1634724000-1634727600@scienceinvancouver.com
SUMMARY:From Discovery to Market: The Role of IP Strategy in Drug Development
DESCRIPTION:Drug development in Canada is a long and complex process\, and the market is competitive. At the heart of drug development is intellectual property (IP). Life sciences companies who develop an IP strategy at the outset of a new project have a competitive advantage by creating value\, generating revenue\, and obtaining market intelligence. Without a strategy\, companies risk losing IP assets\, missing out on investment opportunities\, and being exposed to competition. \nOn Wednesday\, October 20\, join a panel of industry insiders who will discuss the key IP opportunities and strategies related to drug development in Canada. The panel will touch on everything from identifying intellectual property during R&D to the importance of freedom to operate analysis\, international filing strategies and portfolio management\, and of course\, the unique industry challenges brought to light due to the COVID-19 pandemic. \n\n\n\n\n\n\nSpeakers:  \n\nBrian Kingwell\, Partner\, Gowling WLG\nIsabelle Riedl\, Senior Supervisor\, Intellectual Property\, Medicago\nSonia Ziesche\, Principal\, Patent Agent\, Gowling WLG\n\n\n\n\n\n\n\n\n\n\n\n\nEvent Details:\n\n\n\n\n\n\n\n\n\n\n\nDate: Wednesday\, October 20\, 2021 \nTime: 10:00AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/from-discovery-to-market-the-role-of-ip-strategy-in-drug-development-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Gowling-Event-Images-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211020T100000
DTEND;TZID=America/Vancouver:20211020T110000
DTSTAMP:20260404T045652
CREATED:20211004T165959Z
LAST-MODIFIED:20211004T165959Z
UID:28059-1634724000-1634727600@scienceinvancouver.com
SUMMARY:From Discovery to Market: The Role of IP Strategy in Drug Development
DESCRIPTION:Drug development in Canada is a long and complex process\, and the market is competitive. At the heart of drug development is intellectual property (IP). Life sciences companies who develop an IP strategy at the outset of a new project have a competitive advantage by creating value\, generating revenue\, and obtaining market intelligence. Without a strategy\, companies risk losing IP assets\, missing out on investment opportunities\, and being exposed to competition. \nOn Wednesday\, October 20\, join a panel of industry insiders who will discuss the key IP opportunities and strategies related to drug development in Canada. The panel will touch on everything from identifying intellectual property during R&D to the importance of freedom to operate analysis\, international filing strategies and portfolio management\, and of course\, the unique industry challenges brought to light due to the COVID-19 pandemic. \n\n\n\n\n\n\nSpeakers:  \n\nBrian Kingwell\, Partner\, Gowling WLG\nIsabelle Riedl\, Senior Supervisor\, Intellectual Property\, Medicago\nSonia Ziesche\, Principal\, Patent Agent\, Gowling WLG\n\n\n\n\n\n\n\n\n\n\n\n\nEvent Details:\n\n\n\n\n\n\n\n\n\n\n\nDate: Wednesday\, October 20\, 2021 \nTime: 10:00AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/from-discovery-to-market-the-role-of-ip-strategy-in-drug-development-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Gowling-Event-Images-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211020T100000
DTEND;TZID=America/Vancouver:20211020T110000
DTSTAMP:20260404T045652
CREATED:20211004T165959Z
LAST-MODIFIED:20211004T165959Z
UID:31142-1634724000-1634727600@scienceinvancouver.com
SUMMARY:From Discovery to Market: The Role of IP Strategy in Drug Development
DESCRIPTION:Drug development in Canada is a long and complex process\, and the market is competitive. At the heart of drug development is intellectual property (IP). Life sciences companies who develop an IP strategy at the outset of a new project have a competitive advantage by creating value\, generating revenue\, and obtaining market intelligence. Without a strategy\, companies risk losing IP assets\, missing out on investment opportunities\, and being exposed to competition. \nOn Wednesday\, October 20\, join a panel of industry insiders who will discuss the key IP opportunities and strategies related to drug development in Canada. The panel will touch on everything from identifying intellectual property during R&D to the importance of freedom to operate analysis\, international filing strategies and portfolio management\, and of course\, the unique industry challenges brought to light due to the COVID-19 pandemic. \n\n\n\n\n\n\nSpeakers:  \n\nBrian Kingwell\, Partner\, Gowling WLG\nIsabelle Riedl\, Senior Supervisor\, Intellectual Property\, Medicago\nSonia Ziesche\, Principal\, Patent Agent\, Gowling WLG\n\n\n\n\n\n\n\n\n\n\n\n\nEvent Details:\n\n\n\n\n\n\n\n\n\n\n\nDate: Wednesday\, October 20\, 2021 \nTime: 10:00AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/from-discovery-to-market-the-role-of-ip-strategy-in-drug-development-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Gowling-Event-Images-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211020T100000
DTEND;TZID=America/Vancouver:20211020T110000
DTSTAMP:20260404T045652
CREATED:20211004T165959Z
LAST-MODIFIED:20211004T165959Z
UID:32602-1634724000-1634727600@scienceinvancouver.com
SUMMARY:From Discovery to Market: The Role of IP Strategy in Drug Development
DESCRIPTION:Drug development in Canada is a long and complex process\, and the market is competitive. At the heart of drug development is intellectual property (IP). Life sciences companies who develop an IP strategy at the outset of a new project have a competitive advantage by creating value\, generating revenue\, and obtaining market intelligence. Without a strategy\, companies risk losing IP assets\, missing out on investment opportunities\, and being exposed to competition. \nOn Wednesday\, October 20\, join a panel of industry insiders who will discuss the key IP opportunities and strategies related to drug development in Canada. The panel will touch on everything from identifying intellectual property during R&D to the importance of freedom to operate analysis\, international filing strategies and portfolio management\, and of course\, the unique industry challenges brought to light due to the COVID-19 pandemic. \n\n\n\n\n\n\nSpeakers:  \n\nBrian Kingwell\, Partner\, Gowling WLG\nIsabelle Riedl\, Senior Supervisor\, Intellectual Property\, Medicago\nSonia Ziesche\, Principal\, Patent Agent\, Gowling WLG\n\n\n\n\n\n\n\n\n\n\n\n\nEvent Details:\n\n\n\n\n\n\n\n\n\n\n\nDate: Wednesday\, October 20\, 2021 \nTime: 10:00AM – 11:00AM PT \nPlatform: Zoom \nTickets: Free for LSBC members & $25 for LSBC non-members
URL:https://scienceinvancouver.com/event/from-discovery-to-market-the-role-of-ip-strategy-in-drug-development-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/10/Gowling-Event-Images-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211021T113000
DTEND;TZID=America/Vancouver:20211022T140000
DTSTAMP:20260404T045652
CREATED:20210831T201438Z
LAST-MODIFIED:20210831T201438Z
UID:18106-1634815800-1634911200@scienceinvancouver.com
SUMMARY:Cascadia 3.0
DESCRIPTION:BCRegMed and the Institute for Stem Cell & Regenerative Medicine at the University of Washington are proud to host the THIRD ANNUAL Cascadia Regenerative Medicine Symposium. \nThe event will take place October 21st and 22nd at the University of Washington with the option to attend virtually\, and will provide an opportunity for the rich academic talent pools from BC and Washington to share their knowledge and expertise with the community\, generate new collaborative partnerships\, identify existing gaps in the fields of regenerative medicine and cell therapy\, and continue to work toward effective and permanent solutions to some of today’s most challenging and prevalent health care issues. \nOrganized by out friends at UW (Tom Reh\, Jessica Young\, Ron Kwon\, and Kiera Eldred) and BC community (Fabio Rossi\, Nika Shakiba\, and Leili Rohani)\, we invite you to attend our highly anticipated\, two half-day event. \nFor sponsorship opportunities and more information\, please contact our program manager Lisa Borecky: lborecky@bccrc.ca \nThis event is invite only. \nAbstract Deadline: September 15th\nRegistration Deadline: October 7th \nAbstract submission guidelines:\n– Maximum 250 words\n– Unstructured (no headings)\n– Must submit as PDF\n– Please visit this link for example formatting prior to submission
URL:https://scienceinvancouver.com/event/cascadia-3-0/
LOCATION:University of Washington and Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211021T113000
DTEND;TZID=America/Vancouver:20211022T140000
DTSTAMP:20260404T045652
CREATED:20210831T201438Z
LAST-MODIFIED:20210831T201438Z
UID:26428-1634815800-1634911200@scienceinvancouver.com
SUMMARY:Cascadia 3.0
DESCRIPTION:BCRegMed and the Institute for Stem Cell & Regenerative Medicine at the University of Washington are proud to host the THIRD ANNUAL Cascadia Regenerative Medicine Symposium. \nThe event will take place October 21st and 22nd at the University of Washington with the option to attend virtually\, and will provide an opportunity for the rich academic talent pools from BC and Washington to share their knowledge and expertise with the community\, generate new collaborative partnerships\, identify existing gaps in the fields of regenerative medicine and cell therapy\, and continue to work toward effective and permanent solutions to some of today’s most challenging and prevalent health care issues. \nOrganized by out friends at UW (Tom Reh\, Jessica Young\, Ron Kwon\, and Kiera Eldred) and BC community (Fabio Rossi\, Nika Shakiba\, and Leili Rohani)\, we invite you to attend our highly anticipated\, two half-day event. \nFor sponsorship opportunities and more information\, please contact our program manager Lisa Borecky: lborecky@bccrc.ca \nThis event is invite only. \nAbstract Deadline: September 15th\nRegistration Deadline: October 7th \nAbstract submission guidelines:\n– Maximum 250 words\n– Unstructured (no headings)\n– Must submit as PDF\n– Please visit this link for example formatting prior to submission
URL:https://scienceinvancouver.com/event/cascadia-3-0-2/
LOCATION:University of Washington and Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211021T113000
DTEND;TZID=America/Vancouver:20211022T140000
DTSTAMP:20260404T045652
CREATED:20210831T201438Z
LAST-MODIFIED:20210831T201438Z
UID:28043-1634815800-1634911200@scienceinvancouver.com
SUMMARY:Cascadia 3.0
DESCRIPTION:BCRegMed and the Institute for Stem Cell & Regenerative Medicine at the University of Washington are proud to host the THIRD ANNUAL Cascadia Regenerative Medicine Symposium. \nThe event will take place October 21st and 22nd at the University of Washington with the option to attend virtually\, and will provide an opportunity for the rich academic talent pools from BC and Washington to share their knowledge and expertise with the community\, generate new collaborative partnerships\, identify existing gaps in the fields of regenerative medicine and cell therapy\, and continue to work toward effective and permanent solutions to some of today’s most challenging and prevalent health care issues. \nOrganized by out friends at UW (Tom Reh\, Jessica Young\, Ron Kwon\, and Kiera Eldred) and BC community (Fabio Rossi\, Nika Shakiba\, and Leili Rohani)\, we invite you to attend our highly anticipated\, two half-day event. \nFor sponsorship opportunities and more information\, please contact our program manager Lisa Borecky: lborecky@bccrc.ca \nThis event is invite only. \nAbstract Deadline: September 15th\nRegistration Deadline: October 7th \nAbstract submission guidelines:\n– Maximum 250 words\n– Unstructured (no headings)\n– Must submit as PDF\n– Please visit this link for example formatting prior to submission
URL:https://scienceinvancouver.com/event/cascadia-3-0-3/
LOCATION:University of Washington and Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211021T113000
DTEND;TZID=America/Vancouver:20211022T140000
DTSTAMP:20260404T045652
CREATED:20210831T201438Z
LAST-MODIFIED:20210831T201438Z
UID:31126-1634815800-1634911200@scienceinvancouver.com
SUMMARY:Cascadia 3.0
DESCRIPTION:BCRegMed and the Institute for Stem Cell & Regenerative Medicine at the University of Washington are proud to host the THIRD ANNUAL Cascadia Regenerative Medicine Symposium. \nThe event will take place October 21st and 22nd at the University of Washington with the option to attend virtually\, and will provide an opportunity for the rich academic talent pools from BC and Washington to share their knowledge and expertise with the community\, generate new collaborative partnerships\, identify existing gaps in the fields of regenerative medicine and cell therapy\, and continue to work toward effective and permanent solutions to some of today’s most challenging and prevalent health care issues. \nOrganized by out friends at UW (Tom Reh\, Jessica Young\, Ron Kwon\, and Kiera Eldred) and BC community (Fabio Rossi\, Nika Shakiba\, and Leili Rohani)\, we invite you to attend our highly anticipated\, two half-day event. \nFor sponsorship opportunities and more information\, please contact our program manager Lisa Borecky: lborecky@bccrc.ca \nThis event is invite only. \nAbstract Deadline: September 15th\nRegistration Deadline: October 7th \nAbstract submission guidelines:\n– Maximum 250 words\n– Unstructured (no headings)\n– Must submit as PDF\n– Please visit this link for example formatting prior to submission
URL:https://scienceinvancouver.com/event/cascadia-3-0-4/
LOCATION:University of Washington and Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211021T113000
DTEND;TZID=America/Vancouver:20211022T140000
DTSTAMP:20260404T045652
CREATED:20210831T201438Z
LAST-MODIFIED:20210831T201438Z
UID:32586-1634815800-1634911200@scienceinvancouver.com
SUMMARY:Cascadia 3.0
DESCRIPTION:BCRegMed and the Institute for Stem Cell & Regenerative Medicine at the University of Washington are proud to host the THIRD ANNUAL Cascadia Regenerative Medicine Symposium. \nThe event will take place October 21st and 22nd at the University of Washington with the option to attend virtually\, and will provide an opportunity for the rich academic talent pools from BC and Washington to share their knowledge and expertise with the community\, generate new collaborative partnerships\, identify existing gaps in the fields of regenerative medicine and cell therapy\, and continue to work toward effective and permanent solutions to some of today’s most challenging and prevalent health care issues. \nOrganized by out friends at UW (Tom Reh\, Jessica Young\, Ron Kwon\, and Kiera Eldred) and BC community (Fabio Rossi\, Nika Shakiba\, and Leili Rohani)\, we invite you to attend our highly anticipated\, two half-day event. \nFor sponsorship opportunities and more information\, please contact our program manager Lisa Borecky: lborecky@bccrc.ca \nThis event is invite only. \nAbstract Deadline: September 15th\nRegistration Deadline: October 7th \nAbstract submission guidelines:\n– Maximum 250 words\n– Unstructured (no headings)\n– Must submit as PDF\n– Please visit this link for example formatting prior to submission
URL:https://scienceinvancouver.com/event/cascadia-3-0-5/
LOCATION:University of Washington and Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211025T140000
DTEND;TZID=America/Vancouver:20211025T153000
DTSTAMP:20260404T045652
CREATED:20211021T181311Z
LAST-MODIFIED:20211021T181311Z
UID:18902-1635170400-1635175800@scienceinvancouver.com
SUMMARY:Virtual: 2021 Vancouver Gairdner National Symposium
DESCRIPTION:The Vancouver Gairdner High School & National Symposium is held each fall to give students\, teachers\, and the academic community the opportunity to hear from two Gairdner award-winning scientists and learn about the BC Children’s Hospital’s research facilities. \nVirtual UBC Gairdner Symposium \nMonday\, October 25\, 2021 \nTime: 2:00 pm-3:35 pm PST \nJoin via Zoom: Open https://ubc.zoom.us/ and click on ‘Join a Meeting’ \nEnter Meeting ID: 91128 854418 and Passcode: 854418 \nHosted by Dr. Michael Hayden\, Centre for Molecular Medicine and Therapeutics\, University of British Columbia \nEvent Schedule \n2:00 p.m. Welcome by Dr. Hayden & Dr. Verchere \n2:05 p.m. Introduction of Dr. Daniel J. Drucker by Dr. Verchere \n2:08 p.m. Presentation by Dr. Drucker – “Translating Enteroendocrine Hormones into Therapies for Metabolic Disease” \n2:38 p.m. Question period for Dr. Drucker\, moderated by Dr. Verchere \n2:48 p.m. Introduction of Dr. Rodolphe Barrangou by Dr. Hayden \n2:50 p.m. Presentation by Dr. Barrangou – “TBC” \n3:20 p.m. Question period for Dr. Barrangou\, moderated by Dr. Hayden \n3:30 p.m. Closing remarks by Dr. Hayden & Verchere \nStudent Registration\nAll Grade 10-12 students are eligible to participate in the Gairdner High School event. Registration is required https://rc.bcchr.ca/redcap/surveys/?s=TEKDCT34TN
URL:https://scienceinvancouver.com/event/virtual-2021-vancouver-gairdner-national-symposium/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211025T140000
DTEND;TZID=America/Vancouver:20211025T153000
DTSTAMP:20260404T045652
CREATED:20211021T181311Z
LAST-MODIFIED:20211021T181311Z
UID:26451-1635170400-1635175800@scienceinvancouver.com
SUMMARY:Virtual: 2021 Vancouver Gairdner National Symposium
DESCRIPTION:The Vancouver Gairdner High School & National Symposium is held each fall to give students\, teachers\, and the academic community the opportunity to hear from two Gairdner award-winning scientists and learn about the BC Children’s Hospital’s research facilities. \nVirtual UBC Gairdner Symposium \nMonday\, October 25\, 2021 \nTime: 2:00 pm-3:35 pm PST \nJoin via Zoom: Open https://ubc.zoom.us/ and click on ‘Join a Meeting’ \nEnter Meeting ID: 91128 854418 and Passcode: 854418 \nHosted by Dr. Michael Hayden\, Centre for Molecular Medicine and Therapeutics\, University of British Columbia \nEvent Schedule \n2:00 p.m. Welcome by Dr. Hayden & Dr. Verchere \n2:05 p.m. Introduction of Dr. Daniel J. Drucker by Dr. Verchere \n2:08 p.m. Presentation by Dr. Drucker – “Translating Enteroendocrine Hormones into Therapies for Metabolic Disease” \n2:38 p.m. Question period for Dr. Drucker\, moderated by Dr. Verchere \n2:48 p.m. Introduction of Dr. Rodolphe Barrangou by Dr. Hayden \n2:50 p.m. Presentation by Dr. Barrangou – “TBC” \n3:20 p.m. Question period for Dr. Barrangou\, moderated by Dr. Hayden \n3:30 p.m. Closing remarks by Dr. Hayden & Verchere \nStudent Registration\nAll Grade 10-12 students are eligible to participate in the Gairdner High School event. Registration is required https://rc.bcchr.ca/redcap/surveys/?s=TEKDCT34TN
URL:https://scienceinvancouver.com/event/virtual-2021-vancouver-gairdner-national-symposium-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211025T140000
DTEND;TZID=America/Vancouver:20211025T153000
DTSTAMP:20260404T045652
CREATED:20211021T181311Z
LAST-MODIFIED:20211021T181311Z
UID:28066-1635170400-1635175800@scienceinvancouver.com
SUMMARY:Virtual: 2021 Vancouver Gairdner National Symposium
DESCRIPTION:The Vancouver Gairdner High School & National Symposium is held each fall to give students\, teachers\, and the academic community the opportunity to hear from two Gairdner award-winning scientists and learn about the BC Children’s Hospital’s research facilities. \nVirtual UBC Gairdner Symposium \nMonday\, October 25\, 2021 \nTime: 2:00 pm-3:35 pm PST \nJoin via Zoom: Open https://ubc.zoom.us/ and click on ‘Join a Meeting’ \nEnter Meeting ID: 91128 854418 and Passcode: 854418 \nHosted by Dr. Michael Hayden\, Centre for Molecular Medicine and Therapeutics\, University of British Columbia \nEvent Schedule \n2:00 p.m. Welcome by Dr. Hayden & Dr. Verchere \n2:05 p.m. Introduction of Dr. Daniel J. Drucker by Dr. Verchere \n2:08 p.m. Presentation by Dr. Drucker – “Translating Enteroendocrine Hormones into Therapies for Metabolic Disease” \n2:38 p.m. Question period for Dr. Drucker\, moderated by Dr. Verchere \n2:48 p.m. Introduction of Dr. Rodolphe Barrangou by Dr. Hayden \n2:50 p.m. Presentation by Dr. Barrangou – “TBC” \n3:20 p.m. Question period for Dr. Barrangou\, moderated by Dr. Hayden \n3:30 p.m. Closing remarks by Dr. Hayden & Verchere \nStudent Registration\nAll Grade 10-12 students are eligible to participate in the Gairdner High School event. Registration is required https://rc.bcchr.ca/redcap/surveys/?s=TEKDCT34TN
URL:https://scienceinvancouver.com/event/virtual-2021-vancouver-gairdner-national-symposium-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211025T140000
DTEND;TZID=America/Vancouver:20211025T153000
DTSTAMP:20260404T045652
CREATED:20211021T181311Z
LAST-MODIFIED:20211021T181311Z
UID:31149-1635170400-1635175800@scienceinvancouver.com
SUMMARY:Virtual: 2021 Vancouver Gairdner National Symposium
DESCRIPTION:The Vancouver Gairdner High School & National Symposium is held each fall to give students\, teachers\, and the academic community the opportunity to hear from two Gairdner award-winning scientists and learn about the BC Children’s Hospital’s research facilities. \nVirtual UBC Gairdner Symposium \nMonday\, October 25\, 2021 \nTime: 2:00 pm-3:35 pm PST \nJoin via Zoom: Open https://ubc.zoom.us/ and click on ‘Join a Meeting’ \nEnter Meeting ID: 91128 854418 and Passcode: 854418 \nHosted by Dr. Michael Hayden\, Centre for Molecular Medicine and Therapeutics\, University of British Columbia \nEvent Schedule \n2:00 p.m. Welcome by Dr. Hayden & Dr. Verchere \n2:05 p.m. Introduction of Dr. Daniel J. Drucker by Dr. Verchere \n2:08 p.m. Presentation by Dr. Drucker – “Translating Enteroendocrine Hormones into Therapies for Metabolic Disease” \n2:38 p.m. Question period for Dr. Drucker\, moderated by Dr. Verchere \n2:48 p.m. Introduction of Dr. Rodolphe Barrangou by Dr. Hayden \n2:50 p.m. Presentation by Dr. Barrangou – “TBC” \n3:20 p.m. Question period for Dr. Barrangou\, moderated by Dr. Hayden \n3:30 p.m. Closing remarks by Dr. Hayden & Verchere \nStudent Registration\nAll Grade 10-12 students are eligible to participate in the Gairdner High School event. Registration is required https://rc.bcchr.ca/redcap/surveys/?s=TEKDCT34TN
URL:https://scienceinvancouver.com/event/virtual-2021-vancouver-gairdner-national-symposium-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211025T140000
DTEND;TZID=America/Vancouver:20211025T153000
DTSTAMP:20260404T045652
CREATED:20211021T181311Z
LAST-MODIFIED:20211021T181311Z
UID:32609-1635170400-1635175800@scienceinvancouver.com
SUMMARY:Virtual: 2021 Vancouver Gairdner National Symposium
DESCRIPTION:The Vancouver Gairdner High School & National Symposium is held each fall to give students\, teachers\, and the academic community the opportunity to hear from two Gairdner award-winning scientists and learn about the BC Children’s Hospital’s research facilities. \nVirtual UBC Gairdner Symposium \nMonday\, October 25\, 2021 \nTime: 2:00 pm-3:35 pm PST \nJoin via Zoom: Open https://ubc.zoom.us/ and click on ‘Join a Meeting’ \nEnter Meeting ID: 91128 854418 and Passcode: 854418 \nHosted by Dr. Michael Hayden\, Centre for Molecular Medicine and Therapeutics\, University of British Columbia \nEvent Schedule \n2:00 p.m. Welcome by Dr. Hayden & Dr. Verchere \n2:05 p.m. Introduction of Dr. Daniel J. Drucker by Dr. Verchere \n2:08 p.m. Presentation by Dr. Drucker – “Translating Enteroendocrine Hormones into Therapies for Metabolic Disease” \n2:38 p.m. Question period for Dr. Drucker\, moderated by Dr. Verchere \n2:48 p.m. Introduction of Dr. Rodolphe Barrangou by Dr. Hayden \n2:50 p.m. Presentation by Dr. Barrangou – “TBC” \n3:20 p.m. Question period for Dr. Barrangou\, moderated by Dr. Hayden \n3:30 p.m. Closing remarks by Dr. Hayden & Verchere \nStudent Registration\nAll Grade 10-12 students are eligible to participate in the Gairdner High School event. Registration is required https://rc.bcchr.ca/redcap/surveys/?s=TEKDCT34TN
URL:https://scienceinvancouver.com/event/virtual-2021-vancouver-gairdner-national-symposium-5/
LOCATION:Online
END:VEVENT
END:VCALENDAR